<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2010</study_start_year><condition>Adenocarcinoma</condition><condition>Sarcoma</condition><condition>Mesothelioma</condition><condition>Solid Organ Tumors</condition><disease>Adenocarcinoma</disease><disease>Sarcoma</disease><disease>Mesothelioma</disease><disease>Solid Organ Tumors</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2100449</full_dataset_link><location>United States</location><study_start_month>11</study_start_month><keyword>Peritoneal</keyword><keyword>Colorectal</keyword><keyword>Endometrial</keyword><keyword>Lung</keyword><keyword>Ovarian</keyword><keyword>Vulva</keyword><keyword>Persistent</keyword><keyword>Recurrent</keyword><keyword>Assay</keyword><keyword>Uterine Neoplasms</keyword><keyword>Fallopian Tube</keyword><keyword>Chemotherapy</keyword><keyword>Cervical</keyword><keyword>Breast</keyword><keyword>Carcinoid</keyword><keyword>Chemoresponse</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>A Study of ChemoFx Chemoresponse Assay in Solid Tumors - ChemoFx Registry Study</name><description>The purpose of this research study is to collect information from patient’s medical records that had a test called ChemoFx ordered and to understand how doctors may have used the results of the ChemoFx to treat patients with cancer.</description><dates><creation>2010-11-15</creation></dates><accession>2100449</accession><cross_references><ClinicalTrials___gov>NCT01271959</ClinicalTrials___gov></cross_references></HashMap>